Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Annals of Pharmacotherapy|December 31, 2002
Aspirin dose for prevention of cardiovascular disease in diabeticsSandra N Nowak, Linda A Jaber
Journal of Pharmacy Practice|June 30, 2011
Practices of Arab American patients with type 2 diabetes mellitus during RamadanNicole R Pinelli, Linda A Jaber
Diabetes Research and Clinical Practice|January 11, 2018
Safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 1 diabetes: A systematic review and meta-analysisDana El Masri, Samiran Ghosh, Linda A Jaber
Diabetes Research and Clinical Practice|October 24, 2006
Thiazolidinediones and the risk of edema: a meta-analysisHelen D Berlie, James S Kalus, Linda A Jaber
Diabetes Research and Clinical Practice|March 29, 2011
Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alertKathryn M Hurren, Thomas N Taylor, Linda A Jaber
Journal of Clinical Pharmacology|January 26, 2002
Insulin-metformin combination therapy in obese patients with type 2 diabetesLinda A Jaber, Sandra N Nowak, Richard R Slaughter
The Annals of Pharmacotherapy|October 30, 2008
Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysisNicole R Pinelli, Raymond Cha, Morton B Brown, et al.
The Annals of Pharmacotherapy|May 24, 2007
Evolution of peroxisome proliferator-activated receptor agonistsFeng Chang, Linda A Jaber, Helen D Berlie, et al.
Pageof 4